Radiotherapy News and Research

RSS

Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).

BioAlliance Pharma awarded €2 million in funding to study Lauriad mucoadhesive technology

BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, today announced the award of €2 million in funding over 30 months from the « Fond Unique Interministériel » (a French program supporting collaborative research projects) including an amount of €743,000 specifically allocated to BioAlliance Pharma.

5 Mar 2011

New research into drugs to prevent brain tumours in children wins vital funding

New research into drugs which could prevent the return of persistent brain tumours in children has won vital funding from two major brain tumour charities.

5 Mar 2011

ScandiDos, Varian sign distributor agreement for Delta4PT pre-treatment verification system

Varian Medical Systems and ScandiDos AB hereby announce that the companies have signed a non-exclusive distributor agreement. The agreement covers the ScandiDos Delta4PT pre-treatment verification system, for use with Varian's RapidArc radiotherapy technology, the TrueBeam system, and Varian's technology for IMRT.

4 Mar 2011

Varian to highlight new digital image detectors and X-ray tubes at ECR annual meeting

Varian Medical Systems, Inc., X-Ray Products, will be showcasing a comprehensive imaging portfolio of PaxScan® digital image detectors and X-ray tubes for fluoroscopy, angiography, cardiology and cone-beam CT imaging at the European Congress of Radiology (ECR) annual meeting in Vienna, Austria this week.

4 Mar 2011

Infinity commences IPI-926 Phase 2 clinical trial in rare, life-threatening bone cancer

Infinity Pharmaceuticals, Inc. today announced the initiation of a randomized, double-blind Phase 2 clinical trial to evaluate the safety and efficacy of IPI-926 compared to placebo in patients with metastatic or locally advanced, inoperable chondrosarcoma. The trial is expected to enroll over 100 patients worldwide.

3 Mar 2011

New personalized therapy fools cancer cells into killing themselves

A Wayne State University School of Medicine physician-researcher has developed a personalized therapy to treat a wide range of cancers. The treatment is based on a naturally occurring human enzyme that has been genetically modified to fool cancer cells into killing themselves.

1 Mar 2011

Affymetrix introduces new GeneChip miRNA 2.0 Array

Affymetrix, Inc. today launched the GeneChip miRNA 2.0 Array. This enhanced version of its best-in-class microRNA interrogation solution will support the research community's pursuit of personalized medicine by accelerating the identification of biomarkers and gene expression signatures associated with disease.

28 Feb 2011

Innovative miniscule gene transport system can cause breast cancer cells to self-destruct

Scientists at Queen's University Belfast have shown that they can deliver a gene directly into breast cancer cells causing them to self-destruct, using an innovative, miniscule gene transport system, according to research published today in the International Journal of Pharmaceutics.

28 Feb 2011

Study investigates risk of dysphagia after radiotherapy treatment for head & neck cancer

At the 3rd International Conference on innovative approaches in Head and Neck Oncology (ICHNO), Dr Hanna Rahbek Mortensen and colleagues at hospitals and institutes in Denmark presented results from a large prospective trial, the DAHANCA 6 & 7 study. The study, conducted across the country, investigated risk factors for developing dysphagia (swallowing dysfunction), after undergoing radiotherapy treatment for a head & neck cancer.

25 Feb 2011

LinkMed reports fourth quarter net sales of SEK 20.0 million

LinkMed AB: Net sales for the year were SEK 80.5 million. Currency effects had a negative impact on sales of SEK 8 million for the year.

25 Feb 2011

BSD announces inclusion of hyperthermia and chemotherapy for high-risk sarcoma cancer patients

BSD Medical Corporation today announced the inclusion of hyperthermia and chemotherapy as a recommended cancer treatment for Stage IV sarcomas in the "Practice Guidelines in Oncology", which is issued by the National Comprehensive Cancer Network.

25 Feb 2011

ViewRay's radiotherapy treatment planning and delivery software receives FDA marketing clearance

ViewRay™, Inc., a privately held medical device company, has received U.S. FDA marketing clearance for its radiotherapy treatment planning and delivery software.

24 Feb 2011

Pretreatment with FDA-approved drug allows successful pregnancies in radiation-exposed rhesus monkeys

A strategy developed by Massachusetts General Hospital (MGH) researchers to shield the ovaries of female mammals from the damaging effects of radiation and chemotherapy has passed an important milestone. A collaborative study with investigators from Oregon Health and Sciences University (OHSU), published online in the journal Fertility and Sterility, reports that brief preexposure of the ovaries to an FDA-approved agent called FTY720 preserved the fertility of female rhesus monkeys exposed to potentially lethal doses of radiation.

23 Feb 2011

ESMO creates new Community Oncology Working Group to ensure best standards of care

Receiving a cancer diagnosis is a devastating experience. Still under the shock of the bad news, patients must make many choices including who to turn to for advice and treatment, with the possibility to choose among a comprehensive cancer center, a university hospital or a community oncology hospital.

21 Feb 2011

Sleeping Trojan horse technique resolves some difficulties in transporting metal ions into cells

A unique strategy developed by researchers at Cardiff University is opening up new possibilities for improving medical imaging.

18 Feb 2011

World's first cancer stem cell-targeting chemical missile

Deakin University medical scientists have created the world's first cancer stem cell-targeting chemical missile, placing them a step closer to creating a medical 'smart bomb' that would seek out and eradicate the root of cancer cells.

18 Feb 2011

1000th clinical trial added to Cancer Research UK's patient information website

Cancer Research UK has added the 1000th clinical trial to its award winning patient information website, CancerHelp UK, on the 10th anniversary of the launch of its clinical trials database today.

17 Feb 2011

Smoking during radiation treatments reduces chance of overall survival

Smokers who continue to smoke while undergoing radiation treatments for head and neck cancer fare significantly worse than those who quit smoking before therapy, according to a study in the February issue of the International Journal of Radiation Oncology·Biology·Physics, an official journal of the American Society for Radiation Oncology (ASTRO).

16 Feb 2011

UT Southwestern treats breast-cancer patient with Accuray CyberKnife System

Breast-cancer patient Kristin Wiginton is the first to be treated at UT Southwestern Medical Center with high-beam radiation using the Accuray CyberKnife System, which offers improved cosmetic results, less radiation exposure to surrounding tissue and a shorter treatment period.

16 Feb 2011

Diagnosis of breast cancer in women over 70 leads to lower survival

Women over 70 are being diagnosed with breast cancer at a later stage leading to lower survival from the disease in the elderly, new research showed today (Wednesday).

16 Feb 2011

Radiotherapy News and Research

Further Reading

BioAlliance Pharma awarded €2 million in funding to study Lauriad mucoadhesive technology

New research into drugs to prevent brain tumours in children wins vital funding

ScandiDos, Varian sign distributor agreement for Delta4PT pre-treatment verification system

Varian to highlight new digital image detectors and X-ray tubes at ECR annual meeting

Infinity commences IPI-926 Phase 2 clinical trial in rare, life-threatening bone cancer

New personalized therapy fools cancer cells into killing themselves

Affymetrix introduces new GeneChip miRNA 2.0 Array

Innovative miniscule gene transport system can cause breast cancer cells to self-destruct

Study investigates risk of dysphagia after radiotherapy treatment for head & neck cancer

LinkMed reports fourth quarter net sales of SEK 20.0 million

BSD announces inclusion of hyperthermia and chemotherapy for high-risk sarcoma cancer patients

ViewRay's radiotherapy treatment planning and delivery software receives FDA marketing clearance

Pretreatment with FDA-approved drug allows successful pregnancies in radiation-exposed rhesus monkeys

ESMO creates new Community Oncology Working Group to ensure best standards of care

Sleeping Trojan horse technique resolves some difficulties in transporting metal ions into cells

World's first cancer stem cell-targeting chemical missile

1000th clinical trial added to Cancer Research UK's patient information website

Smoking during radiation treatments reduces chance of overall survival

UT Southwestern treats breast-cancer patient with Accuray CyberKnife System

Diagnosis of breast cancer in women over 70 leads to lower survival

Cancer Research eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News